Jerzy Jankowski

Jerzy Jankowski

Auto-generated profile, based on publicly available information

Jerzy Jankowski

Institute of Geophysics

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2006 in Eos
Verified
Journal Article
Open access
PDF file
HBHeinrich Brasse
Heinrich Brasse
AKAnja Kreutzmann
Anja Kreutzmann
VCVaclav Cerv
Vaclav Cerv
TETomasz Ernst
Tomasz Ernst
JJJerzy Jankowski
Jerzy Jankowski
TKToivo Korja
Toivo Korja
The Trans‐European Suture Zone (TESZ) is the largest tectonic boundary in Europe, crossing northwest‐southeast through central Europe from the North Sea to the Black Sea. More than 2000 kilometers long, it constitutes a complex transition between the thick and cold East European Craton (EEQ/Baltic Shield, created more than 650 million years ago (Ma) during the Precambrian, and the warmer, younger Paleozoic (650 to 250 Ma) central European mobile belts.

4 March 2008 in Acta Geophysica
Verified
Journal Article
Closed access
PDF file
JJJerzy Jankowski
Jerzy Jankowski
WJWaldemar Jóźwiak
Waldemar Jóźwiak
JVJan Vozár
Jan Vozár

1 September 2019 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
KKKatarzyna Korzeniowska
Katarzyna Korzeniowska
JJJerzy Jankowski
Jerzy Jankowski
ACArtur Cieslewicz
Artur Cieslewicz
AJAnna Jabłecka
Anna Jabłecka
Cardiovascular diseases and cancer are the most common death causes in the USA and Europe. Moreover, many patients suffer from both of these conditions – a situation which may result from cardiotoxicity of anticancer treatment. In order to reduce the severity of this adverse effect, various methods have been proposed, including the usage of new drug forms and less toxic analogs, omitting the combinations of potentially cardiotoxic drugs and introducing potential cardioprotective agents to the therapy. However, prevention of cardiotoxicity still seems to be insufficient. The article reviews the results of current studies on the use of cardiovascular drugs in the prevention of cardiotoxicity. Based on this knowledge, the most promising cardioprotective drugs seem to be carvedilol, nebivolol, enalapril, and candesartan, as they prevent heart remodeling and correct elevated resting heart rate, which directly affects mortality. Alternatively, in case of adverse reactions, statins might be considered.

5 March 2010 in Acta Geophysica
Verified
Journal Article
Closed access
PDF file
TETomasz Ernst
Tomasz Ernst
JJJerzy Jankowski
Jerzy Jankowski
KNKrzysztof Nowożynski
Krzysztof Nowożynski